However, in GDM and obese pregnancies, lower circulating levels of adiponectin are observed, which correlate positively with fetal overgrowth [12,81,82], suggesting another disrupted metabolic pathway contributing to fetal macrosomia. This evidence concerns the gene ADIPOQ and gestational diabetes.